In association with the BioIndustry Association (BIA), we have conducted our second review of the State of the Discovery Nation.
This year, the report reviews the size and shape of the sector, and then focusses on two technology areas that are set to influence the future of Medicines Discovery:
- Complex (pre-clinical) cell models (CCMs)
- Artificial Intelligence (AI)
In this webinar our CEO, Chris Molloy, will cover the key insights from the report, and how Medicines Discovery Catapult is addressing the findings.